StonvexLoading…
StonvexStonvexStonvexCore line items from FRST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $200.44M | $210.97M | $192.62M | $123.29M |
Operating Income | $72.55M | $-28.90M | $-11.18M | $17.33M |
Net Income | $61.44M | $-16.20M | $-7.83M | $14.15M |
EPS (Diluted) | $2.49 | $-0.66 | $-0.32 | $0.57 |
Total Assets | $4.05B | $3.69B | $3.86B | $3.57B |
Total Liabilities | $3.62B | $3.33B | $3.46B | $3.18B |
Cash & Equivalents | $143.61M | $64.50M | $77.55M | $77.86M |
Free Cash Flow OCF − CapEx | $9.03M | $18.34M | $26.89M | $11.42M |
Shares Outstanding | 24.70M | 24.72M | 24.69M | 24.68M |